Your Voice, Your Vote: 'We need Covid drug Evusheld on the NHS'
BBC - 28 Jun 2024Your Voice, Your Vote: 'We need Covid drug Evusheld on the NHS' ...
evusheld
Your Voice, Your Vote: 'We need Covid drug Evusheld on the NHS' ...
Evusheld (tixagevimab and cilgavimab) for the Prevention of Covid-19
Clinical Trials Arena - 23 Jun 2023Evusheld (tixagevimab and cilgavimab) for the Prevention of Covid-19 ...
Product Highlight - Evusheld
MIMS - 25 Mar 2023Product Highlight - Evusheld ...
AstraZeneca Evusheld: The 200 Best Inventions of 2022
Time Magazine - 10 Nov 2022AstraZeneca Evusheld: The 200 Best Inventions of 2022 ...
Hospitals use a lottery to allocate scarce COVID drugs for the immunocompromised
NPR - 25 Jan 2022Hospitals use a lottery to allocate scarce COVID drugs for the immunocompromised ...
Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants—a prospective cohort study (RESCUE-TX)
The Lancet - 22 Oct 2024Cilgavimab and tixagevimab as pre-exposure prophylaxis in vaccine non-responder kidney transplant recipients during a period of prevalent SARS-CoV-2 BA.2 and BA.4/5 variants—a prospective cohort study (RESCUE-TX) ...
New Omicron offshoot BA.4.6 evades protection of Evusheld’s antibodies, study finds
CNN - 07 Sep 2022New Omicron offshoot BA.4.6 evades protection of Evusheld’s antibodies, study finds ...
How does the COVID-19 prevention drug Evusheld work and who should receive it? An infectious disease specialist explains
The Conversation - 29 Mar 2022How does the COVID-19 prevention drug Evusheld work and who should receive it? An infectious disease specialist explains ...
Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
The New England Journal of Medicine - 20 Apr 2022Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19 ...
EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19
Business Wire - 08 Dec 2021EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19 ...
EMA recommends authorisation of COVID-19 medicine Evusheld
European Medicines Agency - 24 Mar 2022EMA recommends authorisation of COVID-19 medicine Evusheld ...
AstraZeneca's Evusheld slashes risk of symptomatic COVID-19 up to 83%
CIDRAP - 21 Apr 2022AstraZeneca's Evusheld slashes risk of symptomatic COVID-19 up to 83% ...
UK decision not to buy Covid drug Evusheld disappoints charities
The Guardian - 12 Aug 2022UK decision not to buy Covid drug Evusheld disappoints charities ...
AstraZeneca therapy works against Omicron; results mixed for Regeneron
Reuters - 16 Dec 2021AstraZeneca therapy works against Omicron; results mixed for Regeneron ...
Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages
ScienceDirect.com - 21 Jun 2024Preclinical in vivo assessment of the activity of AZD7442 anti-SARS-CoV-2 monoclonal antibodies against Omicron sublineages ...
FDA: Evusheld may not prevent COVID-19 caused by certain variants
American Hospital Association - 05 Oct 2022FDA: Evusheld may not prevent COVID-19 caused by certain variants ...
FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants
CNBC - 26 Jan 2023FDA withdraws Covid antibody treatment Evusheld because it's not effective against 93% of subvariants ...
With rise of new coronavirus variants, FDA halts authorization of Evusheld
CNN - 27 Jan 2023With rise of new coronavirus variants, FDA halts authorization of Evusheld ...
Officials boost access to a drug that can protect the immunocompromised from COVID-19
NPR - 28 Jul 2022Officials boost access to a drug that can protect the immunocompromised from COVID-19 ...